The 5‐HT2C receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment‐seeking individuals

The 5‐HT2C receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment‐seeking individuals

Abstract Alcohol use disorder (AUD) and methamphetamine use disorder (MUD) are prevalent and have high adverse impacts on both the individual and society. Current treatment strategies for these disorders are ineffective at a population level. Lorcaserin, a 5‐HT2C receptor agonist, has shown potentia...

Full description

Bibliographic Details
Main Authors: Erin J. Campbell, Yvonne Bonomo, Adam Pastor, Lisa Collins, Amanda Norman, Peter Galettis, Janice Johnstone, Andrew J. Lawrence
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Pharmacology Research & Perspectives
Subjects:
5‐HT2C agonist
alcohol
craving
lorcaserin
methamphetamine
serotonin
Online Access:https://doi.org/10.1002/prp2.767

Internet

https://doi.org/10.1002/prp2.767

Similar Items